Havrix 720 Junior 720 Unit (Hepatitis a Virus, Inactivated SUSPENSION) 720 UNIT

HAVRIX 720 Junior is a hepatitis A vaccine designed for children, providing protection against the hepatitis A virus. This inactivated suspension is administered intramuscularly and is manufactured by GlaxoSmithKline Inc.

Strength

720 UNIT

Manufacturer / TM Owner

GLAXOSMITHKLINE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HAVRIX 720 Junior is used to prevent hepatitis A infection in children. Hepatitis A is a viral liver disease that can cause mild to severe illness. This vaccine is typically administered to children to build immunity against the virus, helping to reduce the risk of infection and its associated symptoms.

Side Effects

Common effects of HAVRIX 720 Junior may include mild soreness, redness, or swelling at the injection site. Some children may also experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own.

Precautions & Warnings

HAVRIX 720 Junior should be stored as per the manufacturer's instructions to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before administration. Always follow the advice of a healthcare professional regarding vaccination schedules and precautions.

Avoid Interactions

There are no specific interactions widely reported with HAVRIX 720 Junior. However, it is always advisable to inform healthcare providers about any medications or supplements being taken to ensure safety. Avoid taking alcohol or other medications that may weaken the immune system without consulting a healthcare professional.

Frequently Asked Questions

HAVRIX 720 Junior is used to prevent hepatitis A infection in children by building immunity against the virus.

HAVRIX 720 Junior is administered as an intramuscular injection.

Common side effects may include mild soreness, redness, or swelling at the injection site, as well as mild fever, headache, or fatigue.

It is important to consult a healthcare provider before taking HAVRIX 720 Junior with other medications to ensure safety.

HAVRIX 720 Junior should be stored as per the manufacturer's instructions to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.